In order to confirm that DLL enhanced T cell activity in tumor-bearing mice through Mettl3 and Mettl14, we purified T cells and cocultured with 3LL cells treated with DLL and/or overexpressed METL3/14 and evaluated T cell proliferation and IFN-γ secretion. This evidence concerns the gene METTL14 and neoplasm.